Особенности клинического течения ХОБЛ при метаболическом синдроме: роль системного воспаления
Рязанов Алексей Сергеевич, С. А. Киреев, Наталья Николаевна Еременко · CyberLeninK (CyberLeninka) · 2010
Resume. The development of systemic subclinical inflammation is a key element connecting COPD and metabolic syndrome. The purpose of our research comprised in analyzing the parameters of systemic inflammation in patients with COPD with and without metabolic syndrome. Patients with COPD were subdivided into 3 severity levels (GOLD, 2008), another group included patients with COLD combined with metabolic syndrome. We found an increase in levels of interleukin-6, and -8 TNF-α and nonspecific parameters of inflammation (fibrinogen and C-reactive protein) in all groups but more significant increase was registered in case of combination of the pathologies. Thus, combination of metabolic syndrome and COPD results in an increase in the number of proinflammatory cytokines and increase in systemic inflammation.
Cited by 0 works.